FFAR4 and inflammatory bowel disease: To determine whether GPR120 also enhances neutrophil killing of pathogenic bacteria in IBD, we cultured Escherichia coli O83:H1, a pathobiont isolated from a patient with Crohn’s disease24, with CpdA-treated or control neutrophils.